Related Experiment Videos

The Lupus Plasmapheresis Study Group: rationale and updated interim report

H H Euler¹, U M Schwab, J O Schroeder

¹Lupus Plasmapheresis Study Group Clinical Coordinating Center, Second Medical University Clinic, Kiel, Germany.

Artificial Organs

|April 1, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues.

European journal of clinical pharmacology·2021

Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients.

Expert opinion on drug safety·2017

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry.

Leukemia·2016

A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction.

European journal of clinical pharmacology·2016

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.

Leukemia·2016

See all related articles